J. Barry Buzogany
Directeur/Membre du Conseil chez T3D Therapeutics, Inc.
Profil
J.
Barry Buzogany is currently a Director at T3D Therapeutics, Inc. He previously worked as Secretary & General Counsel at Gene Logic, Inc. from 2000 to 2002, Corporate Counsel at Centocor (UK) Ltd.
from 1998 to 1999, and General Counsel at Roche Diagnostics GmbH from 1992 to 1998.
He also held the position of Chief Operating Officer at Cogenics Icoria, Inc. and Principal at Battelle Memorial Institute.
Buzogany received graduate degrees from the University of Southern California and the University of Akron.
Postes actifs de J. Barry Buzogany
| Sociétés | Poste | Début |
|---|---|---|
T3D Therapeutics, Inc.
 T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | Directeur/Membre du Conseil | 01/04/2013 |
Anciens postes connus de J. Barry Buzogany
| Sociétés | Poste | Fin |
|---|---|---|
Gene Logic, Inc.
 Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Conseiller Juridique Général | 01/04/2002 |
Centocor (UK) Ltd.
 Centocor (UK) Ltd. Pharmaceuticals: OtherHealth Technology Part of Johnson & Johnson, Centocor (UK) Ltd. is a British company that specializes in the development, manufacture, and marketing of clinical diagnostic reagents. The company is based in Guildford, UK. | Conseiller Juridique Général | 01/11/1999 |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Conseiller Juridique Général | 01/05/1998 |
Battelle Memorial Institute
 Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Corporate Officer/Principal | - |
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Directeur des opérations | - |
Formation de J. Barry Buzogany
| University of Southern California | Graduate Degree |
| University of Akron | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cogenics Icoria, Inc.
Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC. | Commercial Services |
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Health Technology |
Centocor (UK) Ltd.
Centocor (UK) Ltd. Pharmaceuticals: OtherHealth Technology Part of Johnson & Johnson, Centocor (UK) Ltd. is a British company that specializes in the development, manufacture, and marketing of clinical diagnostic reagents. The company is based in Guildford, UK. | Health Technology |
Roche Diagnostics GmbH
Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
Battelle Memorial Institute
Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Commercial Services |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | Health Technology |
